Tag: juno therapeutics
July 16, 2019
Biotech Market Update: Q2 2019 in Review
With Q2 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share... March 4, 2018
5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase
This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to... February 19, 2018